Patents by Inventor HANNS ULRICH ZEILHOFER

HANNS ULRICH ZEILHOFER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of GABAreceptor modulators for treatment of itch
    Patent number: 11529359
    Abstract: A compound for use in the treatment of itch is provided, wherein the compound comprises the general formula (1a), general formula (1b) or general formula (1c). The compounds of the invention are positive allosteric ?2 and/or ?3 GABAA receptor modulators.
    Type: Grant
    Filed: August 14, 2020
    Date of Patent: December 20, 2022
    Assignee: UNIVERSITAT ZURICH
    Inventors: Hanns Ulrich Zeilhofer, William Ralvenius
  • Use of GABAA receptor modulators for treatment of itch
    Publication number: 20210100814
    Abstract: A compound for use in the treatment of itch is provided, wherein the compound comprises the general formula (1a), general formula (1b) or general formula (1c). The compounds of the invention are positive allosteric ?2 and/or ?3 GABAA receptor modulators.
    Type: Application
    Filed: August 14, 2020
    Publication date: April 8, 2021
    Inventors: Hanns Ulrich Zeilhofer, William Ralvenius
  • Use of n-desmethylclobazam in the treatment of chronic pain disorders and related methods
    Patent number: 10806739
    Abstract: The present invention is directed to N-desmethylclobazam or any suitable pharmaceutically acceptable thereof useful for the prevention and/or treatment of a chronic pain disorder and related methods and pharmaceutical formulations.
    Type: Grant
    Filed: March 2, 2016
    Date of Patent: October 20, 2020
    Assignees: LES HOPITAUX UNIVERSITAIRES DE GENEVE, UNIVERSITAT ZURICH, UNIVERSITE DE GENEVE
    Inventors: Jules Desmeules, Hanns Ulrich Zeilhofer, Marie Besson, Youssef Daali, Alain Matthey, William T. Ralvenius
  • Use of GABAreceptor modulators for treatment of itch
    Patent number: 10786513
    Abstract: A compound for use in the treatment of itch is provided, wherein the compound comprises the general formula (1a), general formula (1b) or general formula (1c). The compounds of the invention are positive allosteric ?2 and/or ?3 GABAA receptor modulators.
    Type: Grant
    Filed: July 25, 2018
    Date of Patent: September 29, 2020
    Assignee: UNIVERSITAT ZURICH
    Inventors: Hanns Ulrich Zeilhofer, William Ralvenius
  • USE OF GABAA RECEPTOR MODULATORS FOR TREATMENT OF ITCH
    Publication number: 20190134057
    Abstract: A compound for use in the treatment of itch is provided, wherein the composed comprises the general formula (1a), general formula (1b) or general formula (1c). The compounds of the invention are positive allosteric ?2 and/or ?3 GABA, receptor modulators.
    Type: Application
    Filed: July 25, 2018
    Publication date: May 9, 2019
    Inventors: Hanns Ulrich Zeilhofer, William Ralvenius
  • USE OF N-DESMETHYLCLOBAZAM IN THE TREATMENT OF CHRONIC PAIN DISORDERS AND RELATED METHODS
    Publication number: 20180161341
    Abstract: The present invention is directed to N-desmethylclobazam or any suitable pharmaceutically acceptable thereof useful for the prevention and/or treatment of a chronic pain disorder and related methods and pharmaceutical formulations.
    Type: Application
    Filed: March 2, 2016
    Publication date: June 14, 2018
    Inventors: JULES DESMEULES, HANNS ULRICH ZEILHOFER, MARIE BESSON, YOUSSEF DAALI, ALAIN MATTHEY, WILLIAM T. RALVENIUS